Alkem Laboratories · NSE: ALKEM · BSE: 539523
Q1 FY23 results · Apr–Jun 2022
Alkem Laboratories reported revenue from operations of ₹2,576.38 crore (down 5.7% from Q1 FY22) and net profit of ₹131.45 crore (down 72.6% from Q1 FY22) for Q1 FY23 (Apr–Jun 2022), on a consolidated basis.
| Item | Q1 FY23 | Q1 FY22 | YoY | Q4 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 2,576.38 | 2,731.36 | −5.7% | 2,483.86 | +3.7% |
| Other income | 51.41 | 46.65 | +10.2% | 20.52 | +150.5% |
| Total income | 2,627.79 | 2,778.01 | −5.4% | 2,504.38 | +4.9% |
| Profit before tax | 151.89 | 556.12 | −72.7% | 242.68 | −37.4% |
| Net profit for the period | 131.45 | 480.23 | −72.6% | 108.21 | +21.5% |
| Attributable to shareholders of the company | 127.64 | 468.12 | −72.7% | 107.58 | +18.7% |
| EPS, basic (₹) | 10.68 | 39.15 | −72.7% | 9.00 | +18.7% |
| Net margin (%) | 5.1 | 17.6 | 4.4 |
| Item | Q1 FY23 | Q1 FY22 | YoY | Q4 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 2,058.35 | 2,278.67 | −9.7% | 2,006.31 | +2.6% |
| Other income | 55.31 | 39.21 | +41.1% | 54.23 | +2.0% |
| Total income | 2,113.66 | 2,317.88 | −8.8% | 2,060.54 | +2.6% |
| Profit before tax | 159.79 | 529.00 | −69.8% | 185.83 | −14.0% |
| Net profit for the period | 140.10 | 469.27 | −70.1% | 76.88 | +82.2% |
| EPS, basic (₹) | 11.72 | 39.25 | −70.1% | 6.43 | +82.2% |
| Net margin (%) | 6.8 | 20.6 | 3.8 |
Consolidated
- Filed with BSE
- 08 Aug 2022, 11:34 IST
- Board meeting
- 05 Aug 2022
- Period
- 01 Apr 2022 to 30 Jun 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 08 Aug 2022, 11:34 IST
- Board meeting
- 05 Aug 2022
- Period
- 01 Apr 2022 to 30 Jun 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE